Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP409072.RA_jjmVS14C6DY4rKkzYb6sgug6EPbkb-6EOS-AxolT9k130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP409072.RA_jjmVS14C6DY4rKkzYb6sgug6EPbkb-6EOS-AxolT9k130_assertion type Assertion NP409072.RA_jjmVS14C6DY4rKkzYb6sgug6EPbkb-6EOS-AxolT9k130_head.
- NP409072.RA_jjmVS14C6DY4rKkzYb6sgug6EPbkb-6EOS-AxolT9k130_assertion wasGeneratedBy ECO_0000203 NP409072.RA_jjmVS14C6DY4rKkzYb6sgug6EPbkb-6EOS-AxolT9k130_provenance.
- NP409072.RA_jjmVS14C6DY4rKkzYb6sgug6EPbkb-6EOS-AxolT9k130_assertion wasDerivedFrom befree-20140225 NP409072.RA_jjmVS14C6DY4rKkzYb6sgug6EPbkb-6EOS-AxolT9k130_provenance.
- NP409072.RA_jjmVS14C6DY4rKkzYb6sgug6EPbkb-6EOS-AxolT9k130_assertion SIO_000772 17164360 NP409072.RA_jjmVS14C6DY4rKkzYb6sgug6EPbkb-6EOS-AxolT9k130_provenance.
- NP409072.RA_jjmVS14C6DY4rKkzYb6sgug6EPbkb-6EOS-AxolT9k130_assertion evidence source_evidence_literature NP409072.RA_jjmVS14C6DY4rKkzYb6sgug6EPbkb-6EOS-AxolT9k130_provenance.
- NP409072.RA_jjmVS14C6DY4rKkzYb6sgug6EPbkb-6EOS-AxolT9k130_assertion description "[We now report that subjects with the XPD Gln/Gln genotype were inversely associated with adenoma risk [odds ratio (OR), 0.7; 95% confidence interval (95% CI), 0.5-1.0] when compared with subjects with the Lys/Lys and Lys/Gln genotypes combined.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP409072.RA_jjmVS14C6DY4rKkzYb6sgug6EPbkb-6EOS-AxolT9k130_provenance.